Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04082143 · ClinicalTrials.gov registry record · Phase 3
CATER: Comprehensive Alveolar and Tooth Esthetic Replacement
A Phase 3 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 3
- Development phase
- 39
- Enrollment target
NCT04082143 is a Phase 3 study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 39 participants.
The verdict
NCT04082143, a Phase 3 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively evaluate whether including an allogeneic gum graft (PerioDerm\*) during dental implant therapy improves implant health and appearance. On the day of implant surgery, participating subjects will be randomized to either receive or not receive a supplemental gum graft along with the implant. Participating subjects will also be asked to complete a brief (about 15 questions) oral health questionnaire. Participating subjects will return to the clinic about 8 weeks post surgery for digital crown impressions and again at 11-13 weeks after surgery for crown placement. Participating subjects will also return to clinic at 1 year after implant placement for implant evaluation. At this final study appointment, x-rays and a 3D intraoral scan will be obtained for the purpose of measuring alveolar volume. The health of the mucosa surrounding the implant and subject satisfaction will be assessed via bleeding upon probing and completion of a brief questionnaire, respectively.
Interventions
- DEVICE Allograft mucosal enhancement with dental implant
- DEVICE No allograft mucosal enhancement at time of dental implant placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-08-25 |
| Est. Completion | 2022-12-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04082143
The ClinicalTrials.gov registry entry for NCT04082143 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Allograft mucosal enhancement with dental implant is the first listed.
NCT04082143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04082143 about?
NCT04082143 is a clinical study titled "CATER: Comprehensive Alveolar and Tooth Esthetic Replacement". The purpose of this study is to prospectively evaluate whether including an allogeneic gum graft (PerioDerm\*) during dental implant therapy improves implant health and appearance. On the day of implant surgery, participating subjects will be randomized to either receive or not receive a supplement...
What is the current status of trial NCT04082143?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 39 participants. The study started on 2019-08-25. Estimated completion is 2022-12-20.
What interventions are being tested in trial NCT04082143?
The interventions under investigation include: Allograft mucosal enhancement with dental implant (DEVICE), No allograft mucosal enhancement at time of dental implant placement (DEVICE).
Who is sponsoring clinical trial NCT04082143?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.